Xilio Therapeutics (XLO) Earnings Date & Reports

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

XLO is expected to report earnings to fall 173.91% to 16 cents per share on May 07

Xilio Therapeutics XLO Stock Earnings Reports

Q1'25

Est.

$0.16

Q4'24

Beat

by $0.04

Q3'24

Beat

by $0.03

Q2'24

Missed

by $0.01

Q1'24

Missed

by $0.51

The last earnings report on February 26 showed earnings per share of -21 cents, beating the estimate of -25 cents. With 1.24M shares outstanding, the current market capitalization sits at 39.68M.

View a ticker or compare two or three

Compare

XLO